1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 AAV 1.2.3 Adenoviral 1.2.4 Lentiviral 1.2.5 Retroviral 1.2.6 Plasmid DNA 1.2.7 Other Vectors 1.3 Market by Application 1.3.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Cancers 1.3.3 Inherited Disorders 1.3.4 Viral Infections 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (2017-2028) 2.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Region (2017-2022) 2.4 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Forecast by Region (2023-2028) 2.5 Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Countries Ranking by Market Size 3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Competitive by Company 3.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Players 3.1.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Players (2017-2022) 3.1.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players (2017-2022) 3.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue 3.4 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio 3.4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2021 3.5 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Key Players Head office and Area Served 3.6 Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service 3.7 Date of Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Breakdown Data by Type 4.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Revenue by Type (2017-2022) 4.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Revenue by Type (2023-2028) 5 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Breakdown Data by Application 5.1 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Historic Market Size by Application (2017-2022) 5.2 Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) 6.2 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2028) 6.3 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2028) 6.4 North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) 7.2 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2028) 7.3 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2028) 7.4 Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) 8.2 Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2028) 8.3 Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2028) 8.4 Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) 9.2 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2028) 9.3 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2028) 9.4 Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) 10.2 Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2028) 10.3 Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2028) 10.4 Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 BioReliance 11.1.1 BioReliance Company Details 11.1.2 BioReliance Business Overview 11.1.3 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.1.4 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.1.5 BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.1.6 BioReliance Recent Developments 11.2 Cobra Biologics 11.2.1 Cobra Biologics Company Details 11.2.2 Cobra Biologics Business Overview 11.2.3 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.2.4 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.2.5 Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.2.6 Cobra Biologics Recent Developments 11.3 Oxford BioMedica 11.3.1 Oxford BioMedica Company Details 11.3.2 Oxford BioMedica Business Overview 11.3.3 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.3.4 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.3.5 Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.3.6 Oxford BioMedica Recent Developments 11.4 UniQure 11.4.1 UniQure Company Details 11.4.2 UniQure Business Overview 11.4.3 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.4.4 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.4.5 UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.4.6 UniQure Recent Developments 11.5 FinVector 11.5.1 FinVector Company Details 11.5.2 FinVector Business Overview 11.5.3 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.5.4 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.5.5 FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.5.6 FinVector Recent Developments 11.6 MolMed 11.6.1 MolMed Company Details 11.6.2 MolMed Business Overview 11.6.3 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.6.4 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.6.5 MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.6.6 MolMed Recent Developments 11.7 MassBiologics 11.7.1 MassBiologics Company Details 11.7.2 MassBiologics Business Overview 11.7.3 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.7.4 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.7.5 MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.7.6 MassBiologics Recent Developments 11.8 Richter-Helm 11.8.1 Richter-Helm Company Details 11.8.2 Richter-Helm Business Overview 11.8.3 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.8.4 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.8.5 Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.8.6 Richter-Helm Recent Developments 11.9 FUJIFILM Diosynth Biotechnologies 11.9.1 FUJIFILM Diosynth Biotechnologies Company Details 11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview 11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.9.5 FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.9.6 FUJIFILM Diosynth Biotechnologies Recent Developments 11.10 Lonza 11.10.1 Lonza Company Details 11.10.2 Lonza Business Overview 11.10.3 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.10.4 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.10.5 Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis 11.10.6 Lonza Recent Developments 11.11 Aldevron 11.11.1 Aldevron Company Details 11.11.2 Aldevron Business Overview 11.11.3 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.11.4 Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.11.5 Aldevron Recent Developments 11.12 Eurogentec 11.12.1 Eurogentec Company Details 11.12.2 Eurogentec Business Overview 11.12.3 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.12.4 Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.12.5 Eurogentec Recent Developments 11.13 Cell and Gene Therapy Catapult 11.13.1 Cell and Gene Therapy Catapult Company Details 11.13.2 Cell and Gene Therapy Catapult Business Overview 11.13.3 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.13.4 Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.13.5 Cell and Gene Therapy Catapult Recent Developments 11.14 Biovian 11.14.1 Biovian Company Details 11.14.2 Biovian Business Overview 11.14.3 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.14.4 Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.14.5 Biovian Recent Developments 11.15 Thermo Fisher Scientific (Brammer Bio) 11.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details 11.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview 11.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments 11.16 VGXI 11.16.1 VGXI Company Details 11.16.2 VGXI Business Overview 11.16.3 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.16.4 VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.16.5 VGXI Recent Developments 11.17 PlasmidFactory 11.17.1 PlasmidFactory Company Details 11.17.2 PlasmidFactory Business Overview 11.17.3 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.17.4 PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.17.5 PlasmidFactory Recent Developments 11.18 bluebird bio 11.18.1 bluebird bio Company Details 11.18.2 bluebird bio Business Overview 11.18.3 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.18.4 bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.18.5 bluebird bio Recent Developments 11.19 Novasep 11.19.1 Novasep Company Details 11.19.2 Novasep Business Overview 11.19.3 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.19.4 Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.19.5 Novasep Recent Developments 11.20 Spark Therapeutics 11.20.1 Spark Therapeutics Company Details 11.20.2 Spark Therapeutics Business Overview 11.20.3 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.20.4 Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.20.5 Spark Therapeutics Recent Developments 11.21 Vigene Biosciences 11.21.1 Vigene Biosciences Company Details 11.21.2 Vigene Biosciences Business Overview 11.21.3 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Products and Services 11.21.4 Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) 11.21.5 Vigene Biosciences Recent Developments 12 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Dynamics 12.1 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Trends 12.2 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers 12.3 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges 12.4 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of AAV Table 3. Key Players of Adenoviral Table 4. Key Players of Lentiviral Table 5. Key Players of Retroviral Table 6. Key Players of Plasmid DNA Table 7. Key Players of Other Vectors Table 8. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 9. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 10. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Region (2017-2022) Table 12. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Players (2017-2022) & (US$ Million) Table 13. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players (2017-2022) Table 14. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2021) Table 15. Ranking of Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Companies by Revenue (US$ Million) in 2021 Table 16. Global 5 Largest Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (CR5 and HHI) & (2017-2022) Table 17. Key Players Headquarters and Area Served Table 18. Key Players Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product Solution and Service Table 19. Date of Key Manufacturers Enter into Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Table 20. Mergers & Acquisitions, Expansion Plans Table 21. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Type (2017-2022) & (US$ Million) Table 22. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2017-2022) Table 23. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 24. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2023-2028) Table 25. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size by Application (2017-2022) & (US$ Million) Table 26. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2017-2022) Table 27. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 28. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2023-2028) Table 29. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) & (US$ Million) Table 30. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2022) & (US$ Million) Table 31. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2023-2028) & (US$ Million) Table 32. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2022) & (US$ Million) Table 33. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2023-2028) & (US$ Million) Table 34. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2022) & (US$ Million) Table 35. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2023-2028) & (US$ Million) Table 36. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) & (US$ Million) Table 37. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2022) & (US$ Million) Table 38. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2023-2028) & (US$ Million) Table 39. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2022) & (US$ Million) Table 40. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2023-2028) & (US$ Million) Table 41. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2022) & (US$ Million) Table 42. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) & (US$ Million) Table 44. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Region (2023-2028) & (US$ Million) Table 50. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) & (US$ Million) Table 51. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2022) & (US$ Million) Table 52. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2023-2028) & (US$ Million) Table 53. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2022) & (US$ Million) Table 54. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2023-2028) & (US$ Million) Table 55. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2022) & (US$ Million) Table 56. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Company (2020-2022) & (US$ Million) Table 58. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2017-2022) & (US$ Million) Table 59. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Type (2023-2028) & (US$ Million) Table 60. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2017-2022) & (US$ Million) Table 61. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Application (2023-2028) & (US$ Million) Table 62. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2017-2022) & (US$ Million) Table 63. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue by Country (2023-2028) & (US$ Million) Table 64. BioReliance Company Details Table 65. BioReliance Business Overview Table 66. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 67. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 68. BioReliance Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 69. BioReliance Recent Developments Table 70. Cobra Biologics Company Details Table 71. Cobra Biologics Business Overview Table 72. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 73. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 74. Cobra Biologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 75. Cobra Biologics Recent Developments Table 76. Oxford BioMedica Company Details Table 77. Oxford BioMedica Business Overview Table 78. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 79. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 80. Oxford BioMedica Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 81. Oxford BioMedica Recent Developments Table 82. UniQure Company Details Table 83. UniQure Business Overview Table 84. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 85. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 86. UniQure Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 87. UniQure Recent Developments Table 88. FinVector Company Details Table 89. FinVector Business Overview Table 90. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 91. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 92. FinVector Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 93. FinVector Recent Developments Table 94. MolMed Company Details Table 95. MolMed Business Overview Table 96. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 97. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 98. MolMed Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 99. MolMed Recent Developments Table 100. MassBiologics Company Details Table 101. MassBiologics Business Overview Table 102. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 103. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 104. MassBiologics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 105. MassBiologics Recent Developments Table 106. Richter-Helm Company Details Table 107. Richter-Helm Business Overview Table 108. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 109. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 110. Richter-Helm Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 111. Richter-Helm Recent Developments Table 112. FUJIFILM Diosynth Biotechnologies Company Details Table 113. FUJIFILM Diosynth Biotechnologies Business Overview Table 114. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 115. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 116. FUJIFILM Diosynth Biotechnologies Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 117. FUJIFILM Diosynth Biotechnologies Recent Developments Table 118. Lonza Company Details Table 119. Lonza Business Overview Table 120. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 121. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 122. Lonza Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing SWOT Analysis Table 123. Lonza Recent Developments Table 124. Aldevron Company Details Table 125. Aldevron Business Overview Table 126. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 127. Aldevron Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 128. Aldevron Recent Developments Table 129. Eurogentec Company Details Table 130. Eurogentec Business Overview Table 131. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 132. Eurogentec Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 133. Eurogentec Recent Developments Table 134. Cell and Gene Therapy Catapult Company Details Table 135. Cell and Gene Therapy Catapult Business Overview Table 136. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 137. Cell and Gene Therapy Catapult Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 138. Cell and Gene Therapy Catapult Recent Developments Table 139. Biovian Company Details Table 140. Biovian Business Overview Table 141. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 142. Biovian Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 143. Biovian Recent Developments Table 144. Thermo Fisher Scientific (Brammer Bio) Company Details Table 145. Thermo Fisher Scientific (Brammer Bio) Business Overview Table 146. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 147. Thermo Fisher Scientific (Brammer Bio) Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 148. Thermo Fisher Scientific (Brammer Bio) Recent Developments Table 149. VGXI Company Details Table 150. VGXI Business Overview Table 151. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 152. VGXI Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 153. VGXI Recent Developments Table 154. PlasmidFactory Company Details Table 155. PlasmidFactory Business Overview Table 156. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 157. PlasmidFactory Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 158. PlasmidFactory Recent Developments Table 159. bluebird bio Company Details Table 160. bluebird bio Business Overview Table 161. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 162. bluebird bio Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 163. bluebird bio Recent Developments Table 164. Novasep Company Details Table 165. Novasep Business Overview Table 166. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 167. Novasep Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 168. Novasep Recent Developments Table 169. Spark Therapeutics Company Details Table 170. Spark Therapeutics Business Overview Table 171. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 172. Spark Therapeutics Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 173. Spark Therapeutics Recent Developments Table 174. Vigene Biosciences Company Details Table 175. Vigene Biosciences Business Overview Table 176. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Product and Services Table 177. Vigene Biosciences Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) & (US$ Million) Table 178. Vigene Biosciences Recent Developments Table 179. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Trends Table 180. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Drivers Table 181. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Challenges Table 182. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Restraints Table 183. Research Programs/Design for This Report Table 184. Key Data Information from Secondary Sources Table 185. Key Data Information from Primary Sources List of Figures Figure 1. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Market Share by Type: 2021 VS 2028 Figure 2. AAV Features Figure 3. Adenoviral Features Figure 4. Lentiviral Features Figure 5. Retroviral Features Figure 6. Plasmid DNA Features Figure 7. Other Vectors Features Figure 8. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Sales Market Share by Application: 2021 VS 2028 Figure 9. Cancers Case Studies Figure 10. Inherited Disorders Case Studies Figure 11. Viral Infections Case Studies Figure 12. Others Case Studies Figure 13. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Report Years Considered Figure 14. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size 2017-2028 (US$ Million) Figure 16. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Size Market Share by Region: 2021 VS 2028 Figure 17. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Region in 2017 VS 2022 Figure 18. Global Top 10 Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Countries Ranking by Market Size (US$ Million) in 2021 Figure 19. Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market Share by Players in 2021 Figure 20. Global Top Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing as of 2021) Figure 21. The Top 10 and 5 Players Market Share by Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue in 2021 Figure 22. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Company in 2021 Figure 23. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2017-2028) Figure 24. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2017-2028) Figure 25. North America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Share by Country (2017-2028) Figure 26. U.S. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 27. Canada Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 28. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Company in 2021 Figure 29. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2017-2028) Figure 30. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2017-2028) Figure 31. Europe Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Share by Country (2017-2028) Figure 32. Germany Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 33. France Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 34. U.K. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 35. Italy Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 36. Russia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 37. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Company in 2021 Figure 38. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2017-2028) Figure 39. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2017-2028) Figure 40. Asia Pacific Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Share by Region (2017-2028) Figure 41. China Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 42. Japan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 43. South Korea Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 44. India Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 45. Australia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 46. Taiwan Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 47. Indonesia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 48. Thailand Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 49. Malaysia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 50. Philippines Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 51. Vietnam Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 52. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Company in 2021 Figure 53. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2017-2028) Figure 54. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2017-2028) Figure 55. Latin America Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Share by Country (2017-2028) Figure 56. Mexico Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 57. Brazil Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 58. Argentina Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 59. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Company in 2021 Figure 60. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Type (2017-2028) Figure 61. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Market Share by Application (2017-2028) Figure 62. Middle East and Africa Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue Share by Country (2017-2028) Figure 63. Turkey Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 64. Saudi Arabia Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 65. UAE Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Revenue (2017-2028) & (US$ Million) Figure 66. BioReliance Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 67. Cobra Biologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 68. Oxford BioMedica Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 69. UniQure Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 70. FinVector Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 71. MolMed Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 72. MassBiologics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 73. Richter-Helm Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 74. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 75. Lonza Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 76. Aldevron Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 77. Eurogentec Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 78. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 79. Biovian Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 80. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 81. VGXI Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 82. PlasmidFactory Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 83. bluebird bio Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 84. Novasep Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 85. Spark Therapeutics Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 86. Vigene Biosciences Revenue Growth Rate in Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Business (2017-2022) Figure 87. Bottom-up and Top-down Approaches for This Report Figure 88. Data Triangulation Figure 89. Key Executives Interviewed

BioReliance Cobra Biologics Oxford BioMedica UniQure FinVector MolMed MassBiologics Richter-Helm FUJIFILM Diosynth Biotechnologies Lonza Aldevron Eurogentec Cell and Gene Therapy Catapult Biovian Thermo Fisher Scientific (Brammer Bio) VGXI PlasmidFactory bluebird bio Novasep Spark Therapeutics Vigene Biosciences